Complex protein interactions underlie many physiological processes involved in development and disease. Over the last decade the traditional toolset used to study protein interactions has expanded. Biological and chemical approaches have been identified that enable high throughput analysis and the identification of molecular probes and drug targets. The Scientist brings together a panel of experts to discuss emerging technologies for studying protein-protein interactions. Attendees will have an opportunity to interact with the experts, ask questions, and seek advice on topics that are unique to their research.
Topics to be covered:
Dr. Michelle Arkin
Associate Professor, Pharmaceutical Chemistry
Associate Director, Small Molecule Discovery Center
University of California, San Francisco
Dr. Xiaolin Nan
Assistant Professor, Department of Biomedical Engineering
Oregon Health & Science University
Dr. Marc Vidal
Director, Center for Cancer Systems Biology
Dana-Farber Cancer Institute
Professor of Genetics, Harvard Medical School
